Todd Hankinson
Concepts (479)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniopharyngioma | 23 | 2025 | 77 | 8.540 |
Why?
| | Pituitary Neoplasms | 20 | 2025 | 190 | 6.670 |
Why?
| | Hydrocephalus | 21 | 2026 | 114 | 4.210 |
Why?
| | Arnold-Chiari Malformation | 14 | 2026 | 29 | 3.510 |
Why?
| | Brain Neoplasms | 29 | 2025 | 1324 | 3.270 |
Why?
| | Neurosurgical Procedures | 14 | 2024 | 207 | 3.110 |
Why?
| | Ventriculoperitoneal Shunt | 12 | 2026 | 44 | 1.900 |
Why?
| | Magnetic Resonance Imaging | 23 | 2026 | 3917 | 1.810 |
Why?
| | Brain Stem Neoplasms | 5 | 2016 | 86 | 1.690 |
Why?
| | Ependymoma | 12 | 2026 | 177 | 1.690 |
Why?
| | Ganglioglioma | 5 | 2025 | 34 | 1.650 |
Why?
| | Child | 98 | 2026 | 22638 | 1.620 |
Why?
| | Decompression, Surgical | 10 | 2026 | 113 | 1.610 |
Why?
| | Cerebrospinal Fluid Shunts | 12 | 2026 | 35 | 1.610 |
Why?
| | Atlanto-Axial Joint | 7 | 2020 | 12 | 1.530 |
Why?
| | Infratentorial Neoplasms | 9 | 2026 | 69 | 1.530 |
Why?
| | Joint Instability | 7 | 2020 | 187 | 1.480 |
Why?
| | Glioma | 7 | 2025 | 425 | 1.460 |
Why?
| | Spinal Injuries | 4 | 2022 | 61 | 1.330 |
Why?
| | Child, Preschool | 52 | 2026 | 11888 | 1.250 |
Why?
| | Spinal Fusion | 9 | 2024 | 264 | 1.230 |
Why?
| | Dura Mater | 4 | 2026 | 40 | 1.200 |
Why?
| | Syringomyelia | 6 | 2026 | 12 | 1.160 |
Why?
| | Pons | 4 | 2016 | 33 | 1.090 |
Why?
| | Occipital Bone | 5 | 2024 | 18 | 1.060 |
Why?
| | Infant | 41 | 2026 | 10093 | 1.040 |
Why?
| | Cervical Atlas | 3 | 2024 | 3 | 1.040 |
Why?
| | Xanthomatosis | 2 | 2017 | 7 | 1.020 |
Why?
| | Sella Turcica | 2 | 2017 | 17 | 1.020 |
Why?
| | Ventriculostomy | 9 | 2026 | 24 | 1.020 |
Why?
| | Cervical Vertebrae | 10 | 2026 | 169 | 1.010 |
Why?
| | Humans | 146 | 2026 | 145625 | 0.970 |
Why?
| | Neurosurgery | 4 | 2025 | 39 | 0.910 |
Why?
| | Tomography, X-Ray Computed | 11 | 2022 | 2766 | 0.890 |
Why?
| | Neuroendoscopy | 6 | 2025 | 24 | 0.880 |
Why?
| | Adolescent | 52 | 2026 | 22451 | 0.820 |
Why?
| | Infant, Newborn | 20 | 2026 | 6449 | 0.800 |
Why?
| | Postoperative Complications | 15 | 2026 | 2962 | 0.800 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2023 | 5 | 0.790 |
Why?
| | Machine Learning | 5 | 2026 | 590 | 0.780 |
Why?
| | Neck Injuries | 1 | 2022 | 22 | 0.730 |
Why?
| | Third Ventricle | 5 | 2025 | 16 | 0.730 |
Why?
| | Male | 78 | 2026 | 73014 | 0.730 |
Why?
| | Neural Tube Defects | 4 | 2019 | 67 | 0.720 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2020 | 774 | 0.710 |
Why?
| | Cellular Senescence | 1 | 2024 | 225 | 0.690 |
Why?
| | Neuroprotection | 1 | 2022 | 46 | 0.690 |
Why?
| | SEER Program | 4 | 2018 | 233 | 0.670 |
Why?
| | Female | 79 | 2026 | 79080 | 0.660 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2026 | 1156 | 0.650 |
Why?
| | Retrospective Studies | 36 | 2026 | 17291 | 0.630 |
Why?
| | Transcriptome | 8 | 2025 | 1066 | 0.620 |
Why?
| | Reoperation | 7 | 2026 | 633 | 0.610 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 91 | 0.610 |
Why?
| | Down Syndrome | 2 | 2020 | 529 | 0.580 |
Why?
| | Perioperative Care | 2 | 2026 | 229 | 0.570 |
Why?
| | Pediatrics | 3 | 2025 | 1122 | 0.560 |
Why?
| | Infant, Premature | 2 | 2026 | 622 | 0.550 |
Why?
| | Brain Injuries, Traumatic | 3 | 2026 | 459 | 0.550 |
Why?
| | Treatment Outcome | 29 | 2026 | 11744 | 0.540 |
Why?
| | Atlanto-Occipital Joint | 3 | 2024 | 4 | 0.540 |
Why?
| | Pituitary Diseases | 1 | 2017 | 20 | 0.510 |
Why?
| | Axis, Cervical Vertebra | 2 | 2022 | 6 | 0.500 |
Why?
| | Meningioma | 1 | 2018 | 87 | 0.500 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 95 | 0.500 |
Why?
| | Decision Support Systems, Clinical | 3 | 2026 | 277 | 0.490 |
Why?
| | Central Nervous System Neoplasms | 2 | 2019 | 177 | 0.490 |
Why?
| | Cerebral Ventricles | 2 | 2022 | 56 | 0.460 |
Why?
| | Skull | 1 | 2017 | 162 | 0.460 |
Why?
| | Intracranial Hemorrhages | 2 | 2020 | 106 | 0.460 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 18 | 0.460 |
Why?
| | EGF Family of Proteins | 1 | 2015 | 17 | 0.450 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2015 | 16 | 0.450 |
Why?
| | Proto-Oncogene Proteins B-raf | 4 | 2025 | 230 | 0.440 |
Why?
| | Receptor, EphA2 | 1 | 2015 | 17 | 0.440 |
Why?
| | Ketorolac | 1 | 2015 | 33 | 0.440 |
Why?
| | Surgical Wound Infection | 4 | 2026 | 331 | 0.440 |
Why?
| | ErbB Receptors | 2 | 2016 | 636 | 0.440 |
Why?
| | Receptor, ErbB-3 | 1 | 2015 | 48 | 0.440 |
Why?
| | Temporal Lobe | 1 | 2015 | 112 | 0.430 |
Why?
| | Neocortex | 2 | 2025 | 49 | 0.430 |
Why?
| | Choroid Plexus Neoplasms | 1 | 2014 | 8 | 0.430 |
Why?
| | src-Family Kinases | 1 | 2015 | 93 | 0.420 |
Why?
| | Meningomyelocele | 3 | 2026 | 63 | 0.410 |
Why?
| | Professional Practice | 1 | 2014 | 58 | 0.400 |
Why?
| | Data Collection | 2 | 2014 | 647 | 0.400 |
Why?
| | Neurosurgeons | 3 | 2025 | 17 | 0.390 |
Why?
| | Delayed Diagnosis | 2 | 2024 | 102 | 0.380 |
Why?
| | Spinal Cord Injuries | 3 | 2024 | 238 | 0.380 |
Why?
| | Cerebral Hemorrhage | 2 | 2026 | 125 | 0.380 |
Why?
| | Quality of Life | 6 | 2026 | 3187 | 0.380 |
Why?
| | Moyamoya Disease | 2 | 2014 | 20 | 0.370 |
Why?
| | Young Adult | 17 | 2021 | 14240 | 0.370 |
Why?
| | Scoliosis | 3 | 2024 | 230 | 0.370 |
Why?
| | Neurology | 1 | 2014 | 107 | 0.370 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 344 | 0.360 |
Why?
| | Intracranial Pressure | 2 | 2026 | 64 | 0.360 |
Why?
| | Follow-Up Studies | 12 | 2026 | 5397 | 0.350 |
Why?
| | Urethral Diseases | 1 | 2011 | 18 | 0.350 |
Why?
| | Foreign-Body Migration | 1 | 2011 | 32 | 0.350 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 377 | 0.340 |
Why?
| | Societies, Medical | 2 | 2025 | 901 | 0.340 |
Why?
| | Genomics | 1 | 2016 | 851 | 0.330 |
Why?
| | Intracranial Hypertension | 2 | 2010 | 42 | 0.330 |
Why?
| | Brain Injuries | 1 | 2016 | 499 | 0.330 |
Why?
| | Observer Variation | 2 | 2025 | 355 | 0.330 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 745 | 0.320 |
Why?
| | Cranial Sutures | 1 | 2010 | 16 | 0.320 |
Why?
| | Craniotomy | 2 | 2008 | 83 | 0.320 |
Why?
| | Epilepsy | 2 | 2025 | 397 | 0.320 |
Why?
| | Odontoid Process | 1 | 2010 | 6 | 0.320 |
Why?
| | Cephalometry | 1 | 2010 | 30 | 0.320 |
Why?
| | Esthetics | 1 | 2010 | 49 | 0.310 |
Why?
| | Internal Fixators | 1 | 2010 | 32 | 0.310 |
Why?
| | Artificial Intelligence | 2 | 2025 | 385 | 0.300 |
Why?
| | Spinal Diseases | 1 | 2010 | 50 | 0.300 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1429 | 0.300 |
Why?
| | Brain Stem | 1 | 2010 | 101 | 0.300 |
Why?
| | Craniosynostoses | 1 | 2010 | 69 | 0.300 |
Why?
| | MAP Kinase Signaling System | 2 | 2024 | 306 | 0.300 |
Why?
| | Biomarkers, Tumor | 3 | 2024 | 1334 | 0.300 |
Why?
| | Urinary Bladder | 1 | 2011 | 194 | 0.290 |
Why?
| | Surgeons | 1 | 2014 | 337 | 0.290 |
Why?
| | Patient Discharge | 1 | 2016 | 991 | 0.290 |
Why?
| | Glomus Tumor | 1 | 2008 | 2 | 0.280 |
Why?
| | Chromosomes, Human, Pair 1 | 2 | 2019 | 81 | 0.270 |
Why?
| | Neuroimaging | 3 | 2020 | 306 | 0.270 |
Why?
| | Anemia, Sickle Cell | 2 | 2014 | 322 | 0.270 |
Why?
| | Orbital Neoplasms | 1 | 2008 | 28 | 0.270 |
Why?
| | Insurance, Liability | 1 | 2008 | 8 | 0.270 |
Why?
| | Cerebral Revascularization | 1 | 2008 | 22 | 0.270 |
Why?
| | Equipment Failure | 3 | 2026 | 111 | 0.270 |
Why?
| | RNA, Messenger | 2 | 2017 | 2783 | 0.270 |
Why?
| | Pyramidal Cells | 2 | 2025 | 80 | 0.270 |
Why?
| | Brain | 5 | 2023 | 2981 | 0.270 |
Why?
| | Prognosis | 8 | 2026 | 4331 | 0.250 |
Why?
| | Medically Underserved Area | 1 | 2008 | 100 | 0.250 |
Why?
| | Adult | 20 | 2025 | 40821 | 0.250 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2020 | 268 | 0.250 |
Why?
| | B7-H1 Antigen | 2 | 2020 | 245 | 0.240 |
Why?
| | Granuloma | 2 | 2017 | 96 | 0.240 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 727 | 0.240 |
Why?
| | Surgical Flaps | 1 | 2008 | 140 | 0.240 |
Why?
| | Astrocytoma | 2 | 2025 | 128 | 0.240 |
Why?
| | Braces | 1 | 2026 | 30 | 0.240 |
Why?
| | Fractures, Compression | 1 | 2026 | 21 | 0.240 |
Why?
| | Lumbar Vertebrae | 2 | 2026 | 259 | 0.230 |
Why?
| | KCNQ2 Potassium Channel | 1 | 2025 | 15 | 0.230 |
Why?
| | 4-Aminopyridine | 1 | 2025 | 30 | 0.230 |
Why?
| | Potassium Channel Blockers | 1 | 2025 | 47 | 0.230 |
Why?
| | Thoracic Vertebrae | 1 | 2026 | 90 | 0.230 |
Why?
| | Autophagy | 2 | 2019 | 290 | 0.230 |
Why?
| | Trastuzumab | 1 | 2026 | 119 | 0.230 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2026 | 39 | 0.230 |
Why?
| | Spinal Fractures | 1 | 2026 | 81 | 0.230 |
Why?
| | Clinical Decision-Making | 2 | 2019 | 364 | 0.220 |
Why?
| | Prosthesis-Related Infections | 1 | 2026 | 99 | 0.220 |
Why?
| | Cranial Fossa, Posterior | 2 | 2026 | 20 | 0.220 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2026 | 158 | 0.220 |
Why?
| | Subdural Effusion | 1 | 2024 | 4 | 0.220 |
Why?
| | Cohort Studies | 9 | 2026 | 6045 | 0.220 |
Why?
| | Interdisciplinary Communication | 1 | 2026 | 200 | 0.210 |
Why?
| | Infant, Premature, Diseases | 1 | 2026 | 113 | 0.210 |
Why?
| | Radiation Injuries | 2 | 2018 | 149 | 0.210 |
Why?
| | United States | 8 | 2025 | 16041 | 0.210 |
Why?
| | Macrophage Activation | 1 | 2025 | 182 | 0.210 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 121 | 0.210 |
Why?
| | Adrenoleukodystrophy | 1 | 2024 | 9 | 0.200 |
Why?
| | Computational Biology | 3 | 2025 | 675 | 0.200 |
Why?
| | Neuronavigation | 1 | 2024 | 8 | 0.200 |
Why?
| | Clonal Evolution | 1 | 2024 | 47 | 0.200 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2024 | 32 | 0.200 |
Why?
| | Reproducibility of Results | 2 | 2025 | 3396 | 0.200 |
Why?
| | Phagocytosis | 1 | 2025 | 298 | 0.200 |
Why?
| | Drainage | 1 | 2024 | 187 | 0.200 |
Why?
| | Microarray Analysis | 4 | 2017 | 117 | 0.200 |
Why?
| | Tumor Burden | 1 | 2024 | 326 | 0.190 |
Why?
| | Combined Modality Therapy | 3 | 2019 | 1269 | 0.190 |
Why?
| | Sensitivity and Specificity | 2 | 2025 | 1992 | 0.190 |
Why?
| | Attitude of Health Personnel | 1 | 2011 | 1212 | 0.190 |
Why?
| | Pineal Gland | 1 | 2022 | 15 | 0.180 |
Why?
| | Pinealoma | 1 | 2022 | 10 | 0.180 |
Why?
| | Germinoma | 1 | 2022 | 10 | 0.180 |
Why?
| | Nerve Net | 1 | 2025 | 284 | 0.180 |
Why?
| | Brain Concussion | 2 | 2022 | 660 | 0.180 |
Why?
| | Cysts | 1 | 2023 | 108 | 0.180 |
Why?
| | Contrast Media | 1 | 2025 | 492 | 0.180 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.180 |
Why?
| | Hedgehog Proteins | 2 | 2022 | 194 | 0.180 |
Why?
| | Nuclear Proteins | 2 | 2025 | 739 | 0.180 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 17 | 0.180 |
Why?
| | Developing Countries | 1 | 2024 | 312 | 0.180 |
Why?
| | Software | 2 | 2025 | 673 | 0.170 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2021 | 194 | 0.170 |
Why?
| | Spine | 1 | 2023 | 184 | 0.170 |
Why?
| | Radiation | 1 | 2021 | 24 | 0.170 |
Why?
| | beta Catenin | 2 | 2024 | 250 | 0.170 |
Why?
| | Endoscopy | 2 | 2015 | 316 | 0.170 |
Why?
| | Chromosome Aberrations | 2 | 2023 | 167 | 0.170 |
Why?
| | Traction | 1 | 2021 | 19 | 0.170 |
Why?
| | Chromatin | 1 | 2025 | 557 | 0.160 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3538 | 0.160 |
Why?
| | Kaplan-Meier Estimate | 4 | 2020 | 959 | 0.160 |
Why?
| | Disease Progression | 3 | 2024 | 2857 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2024 | 530 | 0.160 |
Why?
| | Radiography | 5 | 2026 | 856 | 0.150 |
Why?
| | Preoperative Period | 1 | 2020 | 150 | 0.150 |
Why?
| | Delphi Technique | 4 | 2025 | 347 | 0.150 |
Why?
| | Patient Care Team | 1 | 2026 | 700 | 0.150 |
Why?
| | Sports | 1 | 2022 | 216 | 0.150 |
Why?
| | Neoplasms, Neuroepithelial | 1 | 2019 | 14 | 0.150 |
Why?
| | Risk Factors | 8 | 2026 | 10840 | 0.150 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 81 | 0.150 |
Why?
| | Cerebellar Neoplasms | 1 | 2022 | 169 | 0.150 |
Why?
| | Benchmarking | 1 | 2021 | 192 | 0.150 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2019 | 7 | 0.150 |
Why?
| | Databases, Factual | 2 | 2016 | 1481 | 0.150 |
Why?
| | Medulloblastoma | 1 | 2022 | 208 | 0.150 |
Why?
| | Gene Expression Profiling | 4 | 2020 | 1790 | 0.150 |
Why?
| | Spinal Cord Diseases | 1 | 2019 | 42 | 0.150 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 12 | 0.140 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.140 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2019 | 38 | 0.140 |
Why?
| | Hematoma, Subdural | 1 | 2018 | 20 | 0.140 |
Why?
| | Biomedical Research | 1 | 2025 | 724 | 0.140 |
Why?
| | Neoplasm Grading | 2 | 2021 | 313 | 0.140 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1531 | 0.140 |
Why?
| | Middle Aged | 12 | 2020 | 36359 | 0.140 |
Why?
| | Cerebellum | 1 | 2020 | 225 | 0.140 |
Why?
| | Craniospinal Irradiation | 1 | 2018 | 5 | 0.140 |
Why?
| | Decompressive Craniectomy | 1 | 2018 | 9 | 0.140 |
Why?
| | Spinal Curvatures | 1 | 2018 | 7 | 0.140 |
Why?
| | Specialties, Surgical | 1 | 2019 | 83 | 0.140 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 238 | 0.140 |
Why?
| | Bone Transplantation | 1 | 2018 | 89 | 0.130 |
Why?
| | Phenotype | 2 | 2024 | 3186 | 0.130 |
Why?
| | Skull Neoplasms | 1 | 2017 | 20 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2025 | 728 | 0.130 |
Why?
| | Survival Rate | 3 | 2026 | 2078 | 0.130 |
Why?
| | Stromal Cells | 1 | 2018 | 123 | 0.130 |
Why?
| | Bone Resorption | 1 | 2018 | 80 | 0.130 |
Why?
| | Cyst Fluid | 1 | 2017 | 20 | 0.130 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 212 | 0.130 |
Why?
| | Hypophysitis | 1 | 2017 | 3 | 0.130 |
Why?
| | Macrophages | 1 | 2025 | 1530 | 0.130 |
Why?
| | Fetus | 1 | 2022 | 798 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2020 | 558 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 366 | 0.120 |
Why?
| | Re-Irradiation | 1 | 2016 | 10 | 0.120 |
Why?
| | Nurses | 1 | 2019 | 171 | 0.120 |
Why?
| | Chloroquine | 1 | 2017 | 54 | 0.120 |
Why?
| | Survival Analysis | 2 | 2023 | 1372 | 0.120 |
Why?
| | Sarcoma, Ewing | 1 | 2017 | 103 | 0.120 |
Why?
| | Patient Admission | 1 | 2018 | 216 | 0.120 |
Why?
| | Glioblastoma | 2 | 2010 | 349 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2026 | 1996 | 0.120 |
Why?
| | Aged, 80 and over | 4 | 2018 | 8351 | 0.120 |
Why?
| | Organ Size | 1 | 2017 | 463 | 0.120 |
Why?
| | Age Factors | 3 | 2020 | 3321 | 0.120 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 2218 | 0.120 |
Why?
| | Algorithms | 2 | 2022 | 1843 | 0.120 |
Why?
| | Blood Transfusion | 1 | 2019 | 393 | 0.120 |
Why?
| | Animals | 8 | 2025 | 38030 | 0.120 |
Why?
| | Cetirizine | 1 | 2015 | 2 | 0.110 |
Why?
| | Ambrosia | 1 | 2015 | 5 | 0.110 |
Why?
| | Accidents, Traffic | 2 | 2014 | 192 | 0.110 |
Why?
| | Nasal Sprays | 1 | 2015 | 6 | 0.110 |
Why?
| | Aged | 7 | 2019 | 26251 | 0.110 |
Why?
| | Athletic Injuries | 1 | 2022 | 574 | 0.110 |
Why?
| | Fluticasone | 1 | 2015 | 53 | 0.110 |
Why?
| | Amphiregulin | 1 | 2015 | 27 | 0.110 |
Why?
| | Rhinitis, Allergic, Seasonal | 1 | 2015 | 25 | 0.110 |
Why?
| | Cataract | 1 | 2018 | 238 | 0.110 |
Why?
| | Cytokines | 3 | 2018 | 2079 | 0.110 |
Why?
| | Glasgow Coma Scale | 3 | 2026 | 211 | 0.100 |
Why?
| | Length of Stay | 2 | 2019 | 1342 | 0.100 |
Why?
| | Cerebral Veins | 1 | 2014 | 16 | 0.100 |
Why?
| | Logistic Models | 3 | 2019 | 2112 | 0.100 |
Why?
| | Mice | 7 | 2025 | 18266 | 0.100 |
Why?
| | Chromosomes | 2 | 2024 | 105 | 0.100 |
Why?
| | Mutation | 5 | 2025 | 4082 | 0.100 |
Why?
| | Arachnoid Cysts | 1 | 2013 | 10 | 0.090 |
Why?
| | Central Nervous System Cysts | 1 | 2013 | 12 | 0.090 |
Why?
| | Disease-Free Survival | 1 | 2015 | 777 | 0.090 |
Why?
| | Indoles | 1 | 2017 | 509 | 0.090 |
Why?
| | Sulfonamides | 1 | 2017 | 592 | 0.090 |
Why?
| | Carcinoma | 1 | 2014 | 225 | 0.090 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 10 | 0.090 |
Why?
| | Seasons | 1 | 2015 | 535 | 0.090 |
Why?
| | Imaging, Three-Dimensional | 3 | 2017 | 578 | 0.090 |
Why?
| | Neuropsychological Tests | 2 | 2023 | 1136 | 0.090 |
Why?
| | Cerebral Angiography | 2 | 2014 | 121 | 0.090 |
Why?
| | Up-Regulation | 1 | 2015 | 840 | 0.090 |
Why?
| | Action Potentials | 2 | 2025 | 498 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2019 | 4565 | 0.090 |
Why?
| | Ischemic Attack, Transient | 2 | 2014 | 71 | 0.090 |
Why?
| | Urethra | 1 | 2011 | 55 | 0.090 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1318 | 0.080 |
Why?
| | Treatment Failure | 2 | 2025 | 358 | 0.080 |
Why?
| | Lymphangioma, Cystic | 1 | 2011 | 5 | 0.080 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2011 | 57 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 889 | 0.080 |
Why?
| | Umbilicus | 1 | 2011 | 18 | 0.080 |
Why?
| | Tumor Cells, Cultured | 2 | 2025 | 878 | 0.080 |
Why?
| | Neurologic Examination | 1 | 2011 | 129 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1935 | 0.080 |
Why?
| | Monitoring, Physiologic | 2 | 2026 | 278 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2023 | 2357 | 0.080 |
Why?
| | Brachial Plexus | 1 | 2011 | 34 | 0.080 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2010 | 5 | 0.080 |
Why?
| | Signal Transduction | 2 | 2025 | 5234 | 0.080 |
Why?
| | Registries | 3 | 2025 | 2382 | 0.080 |
Why?
| | Teratoma | 1 | 2011 | 121 | 0.080 |
Why?
| | Rhabdoid Tumor | 1 | 2011 | 99 | 0.080 |
Why?
| | Magnetic Resonance Angiography | 2 | 2014 | 249 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1461 | 0.080 |
Why?
| | Radiosurgery | 1 | 2014 | 398 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2025 | 2497 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1370 | 0.070 |
Why?
| | Skull Fracture, Depressed | 1 | 2008 | 1 | 0.070 |
Why?
| | Prospective Studies | 4 | 2026 | 8087 | 0.070 |
Why?
| | Head Injuries, Closed | 1 | 2008 | 49 | 0.070 |
Why?
| | Zygoma | 1 | 2008 | 7 | 0.070 |
Why?
| | Pia Mater | 1 | 2008 | 4 | 0.070 |
Why?
| | Computer Simulation | 3 | 2021 | 1014 | 0.070 |
Why?
| | Functional Laterality | 1 | 2009 | 240 | 0.070 |
Why?
| | Topography, Medical | 1 | 2008 | 10 | 0.070 |
Why?
| | Diagnosis, Differential | 2 | 2012 | 1500 | 0.070 |
Why?
| | Biopsy | 1 | 2011 | 1073 | 0.070 |
Why?
| | Temporal Arteries | 1 | 2008 | 45 | 0.070 |
Why?
| | Foreign Bodies | 1 | 2008 | 109 | 0.060 |
Why?
| | Electronic Health Records | 1 | 2016 | 1208 | 0.060 |
Why?
| | Models, Anatomic | 1 | 2008 | 87 | 0.060 |
Why?
| | Prenatal Diagnosis | 1 | 2009 | 190 | 0.060 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 193 | 0.060 |
Why?
| | Developmental Disabilities | 1 | 2010 | 280 | 0.060 |
Why?
| | Paraganglioma | 1 | 2008 | 65 | 0.060 |
Why?
| | Diagnostic Imaging | 1 | 2010 | 340 | 0.060 |
Why?
| | Population Dynamics | 1 | 2008 | 142 | 0.060 |
Why?
| | Recurrence | 1 | 2010 | 1125 | 0.060 |
Why?
| | Injections, Spinal | 1 | 2026 | 120 | 0.060 |
Why?
| | Forecasting | 1 | 2008 | 386 | 0.060 |
Why?
| | Cognition Disorders | 1 | 2010 | 547 | 0.060 |
Why?
| | Incidence | 2 | 2026 | 2910 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 563 | 0.060 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 283 | 0.060 |
Why?
| | Gestational Age | 1 | 2009 | 989 | 0.060 |
Why?
| | CD47 Antigen | 1 | 2025 | 41 | 0.060 |
Why?
| | Research Support as Topic | 1 | 2025 | 81 | 0.060 |
Why?
| | Malformations of Cortical Development | 1 | 2025 | 19 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 2008 | 293 | 0.050 |
Why?
| | Cranial Fontanelles | 1 | 2024 | 4 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2026 | 3633 | 0.050 |
Why?
| | Cell Survival | 2 | 2019 | 1102 | 0.050 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2023 | 14 | 0.050 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2024 | 222 | 0.050 |
Why?
| | Intelligence Tests | 1 | 2023 | 55 | 0.050 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2024 | 71 | 0.050 |
Why?
| | Seizures | 1 | 2008 | 489 | 0.050 |
Why?
| | Heart Atria | 1 | 2024 | 139 | 0.050 |
Why?
| | Spinal Cord | 1 | 2026 | 378 | 0.050 |
Why?
| | Stroke | 2 | 2014 | 1283 | 0.050 |
Why?
| | Cranial Irradiation | 1 | 2023 | 85 | 0.050 |
Why?
| | Fluorouracil | 1 | 2024 | 231 | 0.050 |
Why?
| | Sex Factors | 1 | 2009 | 2101 | 0.050 |
Why?
| | Patients' Rooms | 1 | 2022 | 13 | 0.050 |
Why?
| | Drug Resistant Epilepsy | 1 | 2025 | 144 | 0.050 |
Why?
| | Abdomen | 1 | 2023 | 140 | 0.050 |
Why?
| | Narcotics | 1 | 2022 | 57 | 0.040 |
Why?
| | Catheters | 1 | 2022 | 71 | 0.040 |
Why?
| | Gene Ontology | 1 | 2021 | 55 | 0.040 |
Why?
| | NF-kappa B | 1 | 2025 | 674 | 0.040 |
Why?
| | Mass Screening | 1 | 2010 | 1300 | 0.040 |
Why?
| | Vancomycin | 1 | 2022 | 96 | 0.040 |
Why?
| | Slit Ventricle Syndrome | 1 | 2020 | 1 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 218 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 413 | 0.040 |
Why?
| | Transplants | 1 | 2021 | 36 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2021 | 165 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 189 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1758 | 0.040 |
Why?
| | Postoperative Care | 1 | 2022 | 292 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2021 | 303 | 0.040 |
Why?
| | Survivors | 1 | 2023 | 521 | 0.040 |
Why?
| | Chronic Disease | 1 | 2026 | 1824 | 0.040 |
Why?
| | Recovery of Function | 1 | 2024 | 721 | 0.040 |
Why?
| | Genes, APC | 1 | 2019 | 10 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 465 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 360 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2019 | 102 | 0.040 |
Why?
| | Aminopyridines | 1 | 2019 | 128 | 0.040 |
Why?
| | Athletes | 1 | 2022 | 430 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2013 | 1709 | 0.030 |
Why?
| | Critical Care Nursing | 1 | 2019 | 48 | 0.030 |
Why?
| | Benzamides | 1 | 2019 | 226 | 0.030 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 116 | 0.030 |
Why?
| | Surgical Wound | 1 | 2018 | 27 | 0.030 |
Why?
| | Point Mutation | 1 | 2019 | 232 | 0.030 |
Why?
| | Odontogenesis | 1 | 2018 | 12 | 0.030 |
Why?
| | Electronic Mail | 1 | 2018 | 63 | 0.030 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 180 | 0.030 |
Why?
| | Laser Capture Microdissection | 1 | 2018 | 27 | 0.030 |
Why?
| | Weight Gain | 1 | 2022 | 561 | 0.030 |
Why?
| | Standard of Care | 1 | 2018 | 81 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 598 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 82 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2018 | 3005 | 0.030 |
Why?
| | Drug Approval | 1 | 2018 | 93 | 0.030 |
Why?
| | Receptors, HIV | 1 | 2017 | 23 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 345 | 0.030 |
Why?
| | Cytogenetic Analysis | 1 | 2017 | 34 | 0.030 |
Why?
| | Pituitary Gland | 1 | 2018 | 148 | 0.030 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 56 | 0.030 |
Why?
| | Receptors, Interleukin-6 | 1 | 2017 | 49 | 0.030 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1467 | 0.030 |
Why?
| | Mucin-1 | 1 | 2017 | 29 | 0.030 |
Why?
| | Canada | 1 | 2018 | 430 | 0.030 |
Why?
| | Heart-Assist Devices | 1 | 2003 | 570 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 119 | 0.030 |
Why?
| | Blotting, Western | 1 | 2019 | 1176 | 0.030 |
Why?
| | Overweight | 1 | 2022 | 613 | 0.030 |
Why?
| | Brain Diseases | 1 | 2018 | 157 | 0.030 |
Why?
| | Neuroglia | 1 | 2018 | 176 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2003 | 679 | 0.030 |
Why?
| | Prevalence | 2 | 2016 | 2852 | 0.030 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 124 | 0.030 |
Why?
| | Health Surveys | 1 | 2018 | 511 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 928 | 0.030 |
Why?
| | Transcription Factors | 2 | 2017 | 1728 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 304 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 322 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 721 | 0.030 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2018 | 293 | 0.030 |
Why?
| | Drug Synergism | 1 | 2017 | 353 | 0.030 |
Why?
| | Pregnancy | 1 | 2009 | 7217 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1700 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 530 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1160 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 441 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2097 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2019 | 926 | 0.030 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2016 | 295 | 0.030 |
Why?
| | Illinois | 1 | 2013 | 47 | 0.020 |
Why?
| | Chicago | 1 | 2013 | 62 | 0.020 |
Why?
| | Body Mass Index | 1 | 2022 | 2446 | 0.020 |
Why?
| | Quality Improvement | 1 | 2022 | 1325 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 6050 | 0.020 |
Why?
| | Necrosis | 1 | 2013 | 243 | 0.020 |
Why?
| | History, 19th Century | 1 | 2011 | 63 | 0.020 |
Why?
| | SMARCB1 Protein | 1 | 2011 | 32 | 0.020 |
Why?
| | Germany | 1 | 2011 | 139 | 0.020 |
Why?
| | Qualitative Research | 1 | 2019 | 1720 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2436 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2011 | 130 | 0.020 |
Why?
| | Arthritis, Juvenile | 1 | 2011 | 64 | 0.020 |
Why?
| | Abducens Nerve Diseases | 1 | 2010 | 13 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1581 | 0.020 |
Why?
| | History, 20th Century | 1 | 2011 | 330 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 1261 | 0.020 |
Why?
| | Brain Ischemia | 1 | 2014 | 362 | 0.020 |
Why?
| | Joint Dislocations | 1 | 2010 | 60 | 0.020 |
Why?
| | Clothing | 1 | 2008 | 23 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2011 | 437 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3123 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2009 | 423 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2009 | 246 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5875 | 0.010 |
Why?
| | Inflammation | 1 | 2018 | 2915 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2228 | 0.010 |
Why?
| | New York | 1 | 2003 | 127 | 0.010 |
Why?
| | Shock, Cardiogenic | 1 | 2003 | 65 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2003 | 122 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3678 | 0.010 |
Why?
| | Stroke Volume | 1 | 2003 | 651 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2003 | 1037 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2003 | 762 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2003 | 923 | 0.010 |
Why?
| | Time Factors | 1 | 2003 | 7079 | 0.010 |
Why?
| | Heart Failure | 1 | 2003 | 2323 | 0.000 |
Why?
|
|
Hankinson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|